Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway

S Peleg Hasson, T Rubinek, L Ryvo, I Wolf - Breast Care, 2013 - karger.com
Breast cancer is the most common cancer among women. Up to 75% of breast cancers
express the estrogen receptor (ER) α and/or the progesterone receptor (PR). Patients with …

Rapid implementation of telemedicine during the COVID‐19 pandemic: perspectives and preferences of patients with cancer

SP Hasson, B Waissengrin, E Shachar… - The …, 2021 - academic.oup.com
Introduction The use of telemedicine in oncology practice is rapidly expanding and is
considered safe and cost effective. However, the implications of telemedicine on patient …

Comparison of patient susceptibility genes across breast cancer: implications for prognosis and therapeutic outcomes

S Peleg Hasson, T Menes… - Pharmacogenomics and …, 2020 - Taylor & Francis
Hereditary breast cancer syndromes affect a small (10–15% of cases) but significant group
of patients. BRCA1 and BRCA2 are the most familiar and well-studied genes associated …

Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis

S Peleg Hasson, B Salwen, A Sivan, S Shamai… - Clinical Research in …, 2021 - Springer
Background Immune checkpoint inhibitors (ICI) have transformed the standard care of
cancer treatment. Recent case reports describe ICI-mediated myocarditis with an atypical …

Left Atrial Strain changes in patients with breast cancer during anthracycline therapy

M Laufer-Perl, O Arias, SS Dorfman, G Baruch… - International Journal of …, 2021 - Elsevier
Background Cardiotoxicity has become a significant adverse effect of cancer therapy, with
Anthracyclines (ANT) in particular. There is a crucial need for new imaging techniques for …

Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix

SP Hasson, S Felder, L Helpman, A Taylor… - International Journal of …, 2023 - ijgc.bmj.com
Objective The use of chemoradiation in patients with stage IVB cancer of the cervix was
evaluated to determine if definitive treatment offers benefit. Methods A database of 546 …

[HTML][HTML] Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis

S Peleg Hasson, D Hershkovitz, L Adar, M Brezis… - Cancers, 2022 - mdpi.com
Simple Summary Ovarian cancer is the third most common gynecologic cancer and the
eighth most common cause of death from cancer in women. Comprehensive genomic …

Extrapulmonary small cell cancer: a new insight into a rare disease

L Brazg Ferro, I Wolf, S Peleg Hasson, I Golomb… - Oncology, 2021 - karger.com
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The
management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite …

Brain metastases in patients with ovarian cancer

D Limon, E Shachar, I Wolf, L Adar… - Acta …, 2022 - Taylor & Francis
Background Brain metastasis (BM) are uncommon among women with epithelial ovarian
cancer (EOC). The frequency, risk factors and clinical repercussions of BM in these patients …

Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors

SP Hasson, E Shachar, MR Brezis, A Saad… - International Journal of …, 2024 - ijgc.bmj.com
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) play a pivotal role in ovarian
cancer management. With medical cannabis emerging as a novel component of supportive …